1,521.20
+13.4(+0.89%)
Currency In INR
Address
125, Kandivli Industrial Estate
Mumbai, 400067
India
Phone
91 22 6210 5000
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
17335
First IPO Date
January 01, 1996
| Name | Title | Pay | Year Born |
| Prashant Premchand Godha | Executive Director | 69.98M | 1974 |
| Ajit Kumar Bhanwarlal Jain | Chief Financial Officer, MD & Executive Director | 97.67M | 1955 |
| Pranay Godha | Chief Financial Officer, MD & Executive Director | 97.67M | 1972 |
| Premchand Godha A. | Executive Chairman | 135.19M | 1947 |
| Ashok Kumar | President of R&D - Chemicals | 0 | 1954 |
| Harish Kamath | Compliance Officer, Corporate Counsel & Company Secretary | 0 | 1959 |
| Pawan Kothari | Vice President of Operations | 0 | 1965 |
| Saidutta Nanda | President of Human Resources | 0 | N/A |
| Sunil Ghai | President of Marketing | 0 | 1963 |
| Vishnu Saran Singh Kushwaha | Vice President of Technical | 0 | 1968 |
Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
